why choose us

First received: January 21, 2023

Clinical Trial: Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Study Status: Completed

Recruit Status: RECRUITING

Condition: Corneal Ulcer

Study Type: INTERVENTIONAL


Official Title: Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair

Brief Summary: The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow.We previously studied the safety of subconjunctival injection of allogeneic bone marrow-derived MSCs in patients with nonhealing epitheliopathy (IRB Protocol 2020-0334).In the present study, we want to study the efficacy of this treatment on chronic epitheliopathies.

Read more